192 related articles for article (PubMed ID: 18795795)
21. Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica.
Martins M; Pluvinage B; Li de la Sierra-Gallay I; Barbault F; Dairou J; Dupret JM; Rodrigues-Lima F
J Mol Biol; 2008 Nov; 383(3):549-60. PubMed ID: 18778714
[TBL] [Abstract][Full Text] [Related]
22. Arylamine N-acetyltransferases - of mice, men and microorganisms.
Upton A; Johnson N; Sandy J; Sim E
Trends Pharmacol Sci; 2001 Mar; 22(3):140-6. PubMed ID: 11239577
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional characterization of an arylamine N-acetyltransferase from the pathogen Mycobacterium abscessus: differences from other mycobacterial isoforms and implications for selective inhibition.
Cocaign A; Kubiak X; Xu X; Garnier G; Li de la Sierra-Gallay I; Chi-Bui L; Dairou J; Busi F; Abuhammad A; Haouz A; Dupret JM; Herrmann JL; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):3066-79. PubMed ID: 25372695
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
Fullam E; Kawamura A; Wilkinson H; Abuhammad A; Westwood I; Sim E
Protein J; 2009 Aug; 28(6):281-93. PubMed ID: 19636684
[TBL] [Abstract][Full Text] [Related]
25. Kinetic and chemical mechanism of malate synthase from Mycobacterium tuberculosis.
Quartararo CE; Blanchard JS
Biochemistry; 2011 Aug; 50(32):6879-87. PubMed ID: 21728344
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the active site, substrate specificity and kinetic properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver.
Andres HH; Kolb HJ; Schreiber RJ; Weiss L
Biochim Biophys Acta; 1983 Aug; 746(3):193-201. PubMed ID: 6882770
[TBL] [Abstract][Full Text] [Related]
27. Temperature stability of proteins essential for the intracellular survival of Mycobacterium tuberculosis.
Lack NA; Kawamura A; Fullam E; Laurieri N; Beard S; Russell AJ; Evangelopoulos D; Westwood I; Sim E
Biochem J; 2009 Mar; 418(2):369-78. PubMed ID: 19014350
[TBL] [Abstract][Full Text] [Related]
28. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
Brooke EW; Davies SG; Mulvaney AW; Pompeo F; Sim E; Vickers RJ
Bioorg Med Chem; 2003 Apr; 11(7):1227-34. PubMed ID: 12628650
[TBL] [Abstract][Full Text] [Related]
29. The role of lysine(100) in the binding of acetylcoenzyme A to human arylamine N-acetyltransferase 1: implications for other acetyltransferases.
Minchin RF; Butcher NJ
Biochem Pharmacol; 2015 Apr; 94(3):195-202. PubMed ID: 25660616
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.
Sandy J; Mushtaq A; Holton SJ; Schartau P; Noble ME; Sim E
Biochem J; 2005 Aug; 390(Pt 1):115-23. PubMed ID: 15869465
[TBL] [Abstract][Full Text] [Related]
31. Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase.
Westwood IM; Holton SJ; Rodrigues-Lima F; Dupret JM; Bhakta S; Noble ME; Sim E
Biochem J; 2005 Jan; 385(Pt 2):605-12. PubMed ID: 15447630
[TBL] [Abstract][Full Text] [Related]
32. Kinetic mechanism of human histone acetyltransferase P/CAF.
Tanner KG; Langer MR; Denu JM
Biochemistry; 2000 Oct; 39(39):11961-9. PubMed ID: 11009610
[TBL] [Abstract][Full Text] [Related]
33. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
[TBL] [Abstract][Full Text] [Related]
34. Chemical Mechanism of the Branched-Chain Aminotransferase IlvE from Mycobacterium tuberculosis.
Amorim Franco TM; Hegde S; Blanchard JS
Biochemistry; 2016 Nov; 55(45):6295-6303. PubMed ID: 27780341
[TBL] [Abstract][Full Text] [Related]
35. Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N-acetyltransferase (TBNAT) a potential target for novel anti-tubercular agents.
Abuhammad A; Lack N; Schweichler J; Staunton D; Sim RB; Sim E
Protein Expr Purif; 2011 Dec; 80(2):246-52. PubMed ID: 21767648
[TBL] [Abstract][Full Text] [Related]
36. The characteristics of arylamine N-Acetyltransferase in Pseudomonas aeruginosa.
Hsieh SE; Lo HH; Chung JG
Curr Microbiol; 1998 Jun; 36(6):353-60. PubMed ID: 9608747
[TBL] [Abstract][Full Text] [Related]
37. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity.
Mushtaq A; Payton M; Sim E
J Biol Chem; 2002 Apr; 277(14):12175-81. PubMed ID: 11799105
[TBL] [Abstract][Full Text] [Related]
38. Substrate specificity and kinetic mechanism of purine nucleoside phosphorylase from Mycobacterium tuberculosis.
Ducati RG; Santos DS; Basso LA
Arch Biochem Biophys; 2009 Jun; 486(2):155-64. PubMed ID: 19416718
[TBL] [Abstract][Full Text] [Related]
39. Structure and mechanism of arylamine N-acetyltransferases.
Westwood IM; Kawamura A; Fullam E; Russell AJ; Davies SG; Sim E
Curr Top Med Chem; 2006; 6(15):1641-54. PubMed ID: 16918475
[TBL] [Abstract][Full Text] [Related]
40. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.
Zhang N; Liu L; Liu F; Wagner CR; Hanna PE; Walters KJ
J Mol Biol; 2006 Oct; 363(1):188-200. PubMed ID: 16959263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
